Similarly, we found that SNS treatment decreased the level of liver IL-6, which suggests that the beneficial effect of SNS on NAFLD may be partly attributable to the anti-inflammatory effect, including the down-regulated expression of IL-6. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.